ISO 19461-2-2022 PDF

ISO 19461-2-2022 PDF

Radiological protection-Measurement for the clearance of waste contaminated with radioisotopes for medical application-Part 2: Management of solid radioactive waste in nuclear medicine facilities

$96.50 $193.00 -50%
Product Code: ISO 19461-2
Stock In Stock
Edition: 1ST
Published: 06/2022
Number of Pages: 28
File Size: 1 file, 1 Byte

Available Options

Product Description

Radiological protection — Measurement for the clearance of waste contaminated with radioisotopes for medical application — Part 2: Management of solid radioactive waste in nuclear medicine facilities

Introduction: Nuclear medicine is the branch of medicine which uses in vivo radioactive tracers, also called radiopharmaceuticals, to evaluate molecular, metabolic, physiologic or pathologic properties in human beings and animals for diagnosis, monitoring and therapeutic purposes. The use of radionuclides in medicine is a well-established practice. Their favourable physical properties allow a broad use of radionuclides in vivo, in modern medicine. As a result, a wide range of radioactive waste is produced. Most of it is considered biomedical radioactive waste. The amount and types of wastes varies depending on the scale of the nuclear medical facility, the medical applications, and the involved radionuclides. Radioactive waste generated in nuclear medicine facilities does not present a significant long term waste management problem when compared to wastes generated from nuclear fuel cycle operations, for instance. The most important characteristics of biomedical radioactive waste produced in nuclear medicine are its short half-life and low radiotoxicity. It generally contains low-energy photon emitters (<511 keV), but also alpha and beta (β+ and β-) emitters. It is usually of low total and specific activity. Nevertheless, the volume of radioactive waste produced can be significant, and other associated hazards may be present, such as biological and physical risks. The radioactive waste produced is mainly in solid or liquid form. The liquid form is associated with patient urine, since it is

Scope: This document addresses aspects of management of solid biomedical radioactive waste from its generation in nuclear medicine facilities to final clearance and disposal, as well as the manner to establish an effective program for biomedical radioactive waste management. Liquid and gaseous wastes are excluded from the scope of the document, but solid waste includes spent and surplus solutions of radionuclides contained in vials, tubes or syringes. Therefore, this document should be useful for any nuclear medicine facilities dealing with in vivo medical applications of radionuclides and consequently with the waste associated with such applications. This document provides a list of the main radionuclides used in nuclear medicine facilities and their main physical characteristics, as well as the guidance to write a radioactive waste management program for their sorting, collection, packaging and labelling, radioactivity surveys and decay storage, clearance levels, and transportation, if necessary, until their ultimate disposal or discharge. This document may also be useful as guidance for regulatory bodies.

Be the first to write a review for this product.

Write a review

Note: HTML is not translated!
Bad           Good
ISO 19461-2-2022 PDF

ISO 19461-2-2022 PDF

$96.50 $193.00